Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Psychopharmacology

• Publication date

  2017-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/0269881116681399PMID 28093029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia.

  2017cited by this paper
• Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis.

  2015cited by this paper
• Off-Label Prescriptions of Low-Dose Quetiapine and Mirtazapine for Insomnia in The Netherlands

  2015cited by this paper
• Sleep in Schizophrenia: Pathology and Treatment.

  2015cited by this paper
• Insomnia and Somnolence Associated With Second-Generation Antidepressants During the Treatment of Major Depression: A Meta-Analysis

  2015cited by this paper
• Subjective hypnotic efficacy of Trazodone and Mirtazapine in patients with chronic insomnia: a retrospective, comparative study.

  2015cited by this paper
• Sleep and pain sensitivity in adults

  2015cited by this paper
• Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal

  2015cited by this paper
• Prazosin in the Treatment of PTSD

  2014influential reference
• Prospective 8-week trial on the effect of olanzapine, quetiapine, and aripiprazole on blood glucose and lipids among individuals with first-onset schizophrenia

  2014cited by this paper
• Quetiapine for insomnia: A review of the literature.

  2014cited by this paper
• Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.

  2014influential reference
• Behavioral characteristics of subthreshold depression.

  2014cited by this paper
• Insomnia and the risk of incident heart failure: a population study.

  2014cited by this paper
• Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration.

  2014cited by this paper
• Benzodiazepines: Risks and benefits. A reconsideration

  2013cited by this paper
• Effects of low‐dose mirtazapine on driving performance in healthy volunteers

  2013cited by this paper
• Safety of Low Doses of Quetiapine When Used for Insomnia

  2012cited by this paper
• Enhanced slow wave sleep and improved sleep maintenance after gaboxadol administration during seven nights of exposure to a traffic noise model of transient insomnia

  2012cited by this paper
• Cognitive behavioural treatment of insomnia in individuals with persistent persecutory delusions: A pilot trial

  2011cited by this paper
• Serotonin control of sleep-wake behavior.

  2011cited by this paper
• Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss.

  2011influential reference
• Prevalence and factors associated with off-label antidepressant prescriptions for insomnia

  2011cited by this paper
• Benzodiazepines revisited--will we ever learn?

  2011cited by this paper
• A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test.

  2011cited by this paper
• Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the A

  2011cited by this paper
• Measurements of sleepiness and fatigue.

  2010cited by this paper
• Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia

  2010cited by this paper
• Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia

  2010cited by this paper
• Foundations of Psychiatric Sleep Medicine: Depressive disorders

  2010cited by this paper
• Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression.

  2010cited by this paper
• Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression

  2010cited by this paper
• Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents.

  2009cited by this paper
• Mirtazapine induced nightmares in an adult male.

  2009cited by this paper
• Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD).

  2009cited by this paper
• The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies.

  2009cited by this paper
• Metabolic Consequences of Using Low-Dose Quetiapine for Insomnia in Psychiatric Patients

  2009cited by this paper
• Sleep Disturbances in Patients with Schizophrenia

  2008cited by this paper
• Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia.

  2008cited by this paper
• Effects of antipsychotic medications on sleep in schizophrenia

  2008cited by this paper
• InsomnIa and depressIon Cognitive Behavioral Therapy for Insomnia Enhances Depression Outcome in Patients with Comorbid Major Depressive Disorder and Insomnia

  2008cited by this paper
• Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients.

  2007cited by this paper
• The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Techinical Specifications

  2007cited by this paper
• Polysomnographic and Symptomatological Analyses of Major Depressive Disorder Patients Treated with Mirtazapine

  2006cited by this paper
• Depression and sleep: pathophysiology and treatment

  2006cited by this paper
• Changes of Sleep Architecture, Spectral Composition of Sleep EEG, the Nocturnal Secretion of Cortisol, ACTH, GH, Prolactin, Melatonin, Ghrelin, and Leptin, and the DEX-CRH Test in Depressed Patients during Treatment with Mirtazapine

  2006cited by this paper
• Mirtazapine-induced nightmares.

  2006cited by this paper
• Quality of sleep in patients with schizophrenia is associated with quality of life and coping

  2005cited by this paper
• Sleep disturbances in depression and the effects of antidepressants

  2005cited by this paper
• Quetiapine in primary insomnia: a pilot study

  2005influential reference
• Neuropsychological Assessment, 4th ed.

  2005cited by this paper
• Effects of repeated ritanserin on middle-aged poor sleepers

  2004cited by this paper
• Sleep-promoting properties of quetiapine in healthy subjects

  2004influential reference
• Sleep in schizophrenia patients and the effects of antipsychotic drugs.

  2004cited by this paper
• Effect of the antidepressant Org 3770 on human sleep

  2004cited by this paper
• Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.

  2003cited by this paper
• Subjective assessment of the effects of CNS‐active drugs on sleep by the Leeds sleep evaluation questionnaire: a review

  2003cited by this paper
• Effects of Mirtazapine on Sleep Polygraphic Variables in Major Depression

  2003cited by this paper
• The effects of mirtazapine on plasma lipid profiles in healthy subjects.

  2003cited by this paper
• The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers.

  2002influential reference
• The relationship between insomnia and health-related quality of life in patients with chronic illness.

  2002cited by this paper
• Tolerance to Daytime Sedative Effects of H1 Antihistamines

  2002cited by this paper
• Subjective measurement of insomnia and quality of life in depressed inpatients

  2000cited by this paper
• Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study.

  2000cited by this paper
• Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens.

  2000cited by this paper
• Sedation and antihistamines: a review of inter‐drug differences using proportional impairment ratios

  2000cited by this paper
• Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.

  1999cited by this paper
• Serotonin-2 Receptors and Human Sleep: Effect of a Selective Antagonist on EEG Power Spectra

  1999cited by this paper
• Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists.

  1999influential reference
• Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem.

  1995cited by this paper
• Sleepiness and performance during three-day administration of cetirizine or diphenhydramine.

  1994cited by this paper
• The International Classification of Sleep Disorders

  1992cited by this paper
• A dose-response study examining the effects of ritanserin on human slow wave sleep.

  1991cited by this paper
• Subjective and objective sleepiness in the active individual.

  1990influential reference
• A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour.

  1975cited by this paper
• Depressive disorders.

  1974cited by this paper

• Comparative acceptability of first-line antidepressants among older adults using filled prescription sequences: A nationwide cohort study.

  2026cites this paper
• Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology

  2025influential citation
• Mirtazapine for chronic insomnia in older adults: a randomised double-blind placebo-controlled trial-the MIRAGE study.

  2025cites this paper
• Medication Prescribing Patterns at a Youth Mental Health Service: A Single Center Retrospective Cross-sectional Study

  2025cites this paper
• De la escucha al alivio: enfoques prácticos en el manejo del insomnio (parte II)

  2025cites this paper
• Sleep–Wake Disorders After Traumatic Brain Injury: Pathophysiology, Clinical Management, and Future

  2025cites this paper
• Mirtazapine for chronic insomnia in older adults: weighing the risks and potential benefits.

  2025cites this paper
• Clinical Management of Insomnia in Adults

  2025cites this paper
• Effects of gender and age on sleep EEG functional connectivity differences in subjects with mild difficulty falling asleep

  2024cites this paper
• Effects of Mood Stabilizers on Sleep and Circadian Rhythms: A Systematic Review

  2024cites this paper
• Insomnia in the elderly and contemporary treatment methods

  2024cites this paper
• Mirtazapine blood levels and antidepressant response

  2024cites this paper
• Psychopharmacoepidemiological trends in the Portuguese territory during the pandemic and post-pandemic periods (2019-2022)

  2024cites this paper
• Insomnia medications: History, characteristics, and guidelines for optimal use in clinical practice

  2023influential citation
• Effects of the antipsychotic quetiapine on sleep and breathing: a review of clinical findings and potential mechanisms

  2023cites this paper
• Psychopharmacological treatments in Down syndrome and autism spectrum disorder: State of the research and practical considerations

  2023cites this paper
• 2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults – Brazilian Sleep Association

  2023cites this paper
• Relationship between falls and the use of hypnotics, antidepressants, antipsychotics, and anxiolytics in patients with rheumatoid arthritis: A cross-sectional study.

  2023cites this paper
• Mirtazapine: A One-Stop Strategy for Treatment of Opioid Withdrawal Symptoms

  2023cites this paper
• Excessive Daytime Sleepiness and Insomnia Symptoms in Adolescents With Major Depressive Disorder: Prevalence, Clinical Correlates, and the Relationship With Psychiatric Medications Use

  2023cites this paper
• Effect of Mirtazapine on Nausea in Children with Functional Nausea and Functional Dyspepsia Postprandial Distress Syndrome

  2022cites this paper
• Propensity score-matching analysis comparing safety outcomes of appetite-stimulating medications in oncology patients

  2022cites this paper
• Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort

  2022cites this paper
• Translational approaches to influence sleep and arousal

  2022cites this paper
• National prescription patterns of antidepressants among patients with amyotrophic lateral sclerosis: An analysis of the Korean National Health Insurance database

  2022cites this paper
• Weight-centric treatment of depression and chronic pain

  2022cites this paper
• Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials.

  2022cites this paper
• Sleep Disturbances Following Traumatic Brain Injury

  2022cites this paper
• Difference in the regulation of biological rhythm symptoms of Major depressive disorder between escitalopram and mirtazapine.

  2021cites this paper
• Insomnia due to drug or substance abuse and dependence

  2021cites this paper
• Multitargeting the sleep-pain interaction with pharmacological approaches: A narrative review with suggestions on new avenues of investigation.

  2021cites this paper
• Recent Advances in Diagnosis and Treatment of Insomnia Disorder

  2020cites this paper
• Mirtazapine for sleep disturbances in Angelman syndrome: a retrospective chart review of 8 pediatric cases

  2020cites this paper
• Mirtazapine and Depressions

  2020cites this paper
• Rhabdomyolysis With Clozapine and Haloperidol Coadministration: A Case Report.

  2020cites this paper
• Initiation of antidepressant use among refugee and Swedish-born youth after diagnosis of a common mental disorder: findings from the REMAIN study

  2020cites this paper
• Protective role of mirtazapine in adult female Mecp2+/− mice and patients with Rett syndrome

  2020cites this paper
• Low-dose Quetiapine for Major Depressive Disorder and Sleep Improvement.

  2020cites this paper
• Psychofarmaca en de behandeling van slaapstoornissen

  2020cites this paper
• Brief psychotic disorder associated with quarantine and mild COVID-19

  2020cites this paper
• The management of post-traumatic stress disorder and associated pain and sleep disturbance in refugees

  2019cites this paper
• Role of sleep deprivation in the causation of postpartum obsessive-compulsive disorder.

  2019cites this paper
• Sleep-Related Disorders in Neurology and Psychiatry.

  2019cites this paper
• Behandeling met psychofarmaca bij cliënten met antisociaal gedrag of een antisociale persoonlijkheidsstoornis

  2019cites this paper
• Feasibility of Using a Wearable Biosensor Device in Patients at Risk for Alzheimer’s Disease Dementia

  2019cites this paper
• [Acute insomnia: natural course and correction modalities].

  2019cites this paper
• Pharmacotherapy of depression in patients with advanced diseases

  2019cites this paper
• British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update

  2019cites this paper
• Pharmacological treatment for insomnia in patients with major depressive disorder

  2019cites this paper
• Validation of the adapted Leeds sleep evaluation questionnaire in Ethiopian university students

  2018cites this paper
• Antidepressants for insomnia in adults.

  2018cites this paper
• Pharmacological management of sleep after traumatic brain injury

  2018cites this paper
• Newly Initiated In-Hospital Antipsychotics Continued at Discharge in Non-psychiatric Patients

  2018cites this paper
• Making sleep easier: pharmacological interventions for insomnia

  2018cites this paper
• Insomnia: Will Medication Bring Rest?

  2018cites this paper
• A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples

  2018cites this paper
• Understanding sleep-wake mechanisms and drug discovery

  2017cites this paper
• TBI and Sleep–Wake Disorders: Pathophysiology, Clinical Management, and Moving towards the Future

  2017cites this paper